Oneness Biotech’s innovative diabetic foot ulcer treatment, ON101, has been selected among the Top 15 companies worldwide in the ADA 2026 Innovation Challenge.Read More
Oneness Biotech presented today at the J.P. Morgan Healthcare Conference, one of the world’s most influential healthcare investment events. President Dr. Shuling Cheng outlined the company’s global strategy and growth platform, emphasizing Oneness’ commitment to building a leading metabolic disease company. A key focus of the presentation was Bonvadis® (ON101) and its role in redefining wound care and limb preservation. Read More
Meet Bonvadis® at Pisa: Botanical, FDA-cleared medical device designed for chronic wound healing Proven to reduce amputation risk and accelerate DFU healing (80% in real-world setting, even with infection) Backed by clinical evidence, including a Mayo Clinic–published studyRead More
Oneness Biotech is excited to join the 16th International Diabetic Foot Course (Oct 1–4, 2025, Hotel San Ranieri, Pisa, Italy), a premier global platform where clinicians, researchers, and industry leaders come together with a shared mission: advancing DFU care and improving patient outcomes.Read More
Dr. Brock Liden, an internationally recognized podiatrist with more than 25 years of experience in chronic wound management, delivered one of the most engaging sessions at SAWC Fall 2025. His presentation explored how consistent wound-bed management and supportive topical therapy can help drive wound progression in both diabetic foot ulcers (DFUs) and venous leg ulcers...Read More
Dr. Shih highlighted a harsh reality: elderly DFU patients face higher rates of non-healing, infection, and major amputation compared with younger populations, due largely to PAD, long-standing diabetes, and impaired perfusion . Despite careful offloading and SOC, many wounds stagnate unless inflammation is addressed directly.Read More
At SAWC Fall 2025, Dr. Daniel L. Kapp, board-certified plastic surgeon and nationally recognized authority in wound reconstruction and biologic therapies, led an insightful session on the growing clinical burden of non-healing post-surgical wounds and the emerging strategies for supporting faster, more predictable recovery.Read More
Oneness Biotech Co., Ltd. is proud to announce its participation in the Symposium on Advanced Wound Care (SAWC) Fall 2025, taking place in the United States. As one of the leading events in the field of wound care, SAWC Fall attracts thousands of clinicians, researchers, and industry professionals from around the world.Read More
